Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Cash And Cash Equivalents At Carrying Value of $791.30 million for the year ending 2025.
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +63.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from WEST PHARMACEUTICAL SERVICES INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2010 to 2025), WEST PHARMACEUTICAL SERVICES INC's Cash And Cash Equivalents At Carrying Value has grown by 618.1%.
- Historical annual values: Fiscal year 2025: $791.30 million | Fiscal year 2024: $484.60 million | Fiscal year 2023: $853.90 million | Fiscal year 2022: $894.30 million | Fiscal year 2021: $762.60 million | Fiscal year 2020: $615.50 million | Fiscal year 2019: $439.10 million | Fiscal year 2018: $337.40 million | Fiscal year 2017: $235.90 million | Fiscal year 2016: $203.00 million | Fiscal year 2015: $274.60 million | Fiscal year 2014: $255.30 million | Fiscal year 2013: $230.00 million | Fiscal year 2012: $161.90 million | Fiscal year 2011: $91.80 million | Fiscal year 2011: $161.90 million | Fiscal year 2010: $110.20 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: